Think of it this way: GLP-1 reduces input (food consumed), GIP optimizes processing (nutrient partitioning), and glucagon increases output (energy expenditure)
The targets are the GLP-1 receptor (glucagon-like peptide-1), the GIP receptor (glucose-dependent insulinotropic polypeptide), and the glucagon receptor
Together, these two incretins contribute to metabolic homeostasis, preventing both hyperglycemia and hypoglycemia, mitigating dyslipidemia, and reducing the risk of cardiovascular diseases in individuals with type 2 diabetes and obesity
Blood Sugar Management: This process helps the body maintain stable blood glucose levels
10 Myth : All GLP-1 agonists work the same for all people
The same individual on retatrutide might reach approximately 214 pounds (86 pounds lost)